A Phase 1b Open Label Study to Evaluate the Safety, Tolerability and Pharmacokinetic of AMG 479 with Biologics or Chemotherapy in Adult Subjects with Advanced Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 02 Nov 2016
At a glance
- Drugs Ganitumab (Primary) ; Bevacizumab; Erlotinib; Gemcitabine; Panitumumab; Sorafenib
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 29 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Sep 2011 Actual end date (April 2011) added as reported by ClinicalTrials.gov.
- 27 Mar 2010 Planned end date changed from 1 Oct 2010 to 1 Nov 2010 as reported by ClinicalTrials.gov.